Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,834 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Trimethoprim sulfamethoxazole-induced sweet syndrome.
Azfar RS, Cohn J, Schaffer A, Kim EJ. Azfar RS, et al. Among authors: kim ej. Arch Dermatol. 2009 Feb;145(2):215-6. doi: 10.1001/archderm.145.2.215. Arch Dermatol. 2009. PMID: 19221284 No abstract available.
Congestive heart failure in a patient with cutaneous T-cell lymphoma treated with low-dose interferon alfa-2b.
Evans KG, Loren AW, Rook AH, Kim EJ, Glassberg HL. Evans KG, et al. Among authors: kim ej. Arch Dermatol. 2011 Sep;147(9):1122-3. doi: 10.1001/archdermatol.2011.246. Arch Dermatol. 2011. PMID: 21931064 No abstract available.
Tumor necrosis factor inhibitor-associated dermatomyositis.
Klein R, Rosenbach M, Kim EJ, Kim B, Werth VP, Dunham J. Klein R, et al. Among authors: kim ej, kim b. Arch Dermatol. 2010 Jul;146(7):780-4. doi: 10.1001/archdermatol.2010.142. Arch Dermatol. 2010. PMID: 20644041 Free PMC article.
Sweet syndrome associated with new-onset systemic lupus erythematosus in a 25-year-old man.
Fernandes NF, Castelo-Soccio L, Kim EJ, Werth VP. Fernandes NF, et al. Among authors: kim ej. Arch Dermatol. 2009 May;145(5):608-9. doi: 10.1001/archdermatol.2009.82. Arch Dermatol. 2009. PMID: 19451520 Free PMC article. No abstract available.
The addition of interferon gamma to oral bexarotene therapy with photopheresis for S├ęzary syndrome.
McGinnis KS, Ubriani R, Newton S, Junkins-Hopkins JM, Vittorio CC, Kim EJ, Wysocka M, Rook AH. McGinnis KS, et al. Among authors: kim ej. Arch Dermatol. 2005 Sep;141(9):1176-8. doi: 10.1001/archderm.141.9.1176. Arch Dermatol. 2005. PMID: 16172331 No abstract available.
High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response.
Raphael BA, Shin DB, Suchin KR, Morrissey KA, Vittorio CC, Kim EJ, Gardner JM, Evans KG, Introcaso CE, Samimi SS, Gelfand JM, Rook AH. Raphael BA, et al. Among authors: kim ej. Arch Dermatol. 2011 Dec;147(12):1410-5. doi: 10.1001/archdermatol.2011.232. Epub 2011 Aug 15. Arch Dermatol. 2011. PMID: 21844430
Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma.
Gardner JM, Evans KG, Goldstein S, Kim EJ, Vittorio CC, Rook AH. Gardner JM, et al. Among authors: kim ej. Arch Dermatol. 2009 Sep;145(9):985-8. doi: 10.1001/archdermatol.2009.229. Arch Dermatol. 2009. PMID: 19770436 No abstract available.
Low-dose bexarotene and low-dose interferon alfa-2b for adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1.
Richardson S, Budgin JB, Junkins-Hopkins JM, Vittorio CC, Lee J, Miller WT Jr, Rook AH, Kim EJ. Richardson S, et al. Among authors: kim ej. Arch Dermatol. 2005 Mar;141(3):301-4. doi: 10.1001/archderm.141.3.301. Arch Dermatol. 2005. PMID: 15781670 No abstract available.
CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE, Kim EJ, Gardner J, Junkins-Hopkins JM, Vittorio CC, Rook AH. Introcaso CE, et al. Among authors: kim ej. Arch Dermatol. 2008 Aug;144(8):1027-9. doi: 10.1001/archderm.144.8.1027. Arch Dermatol. 2008. PMID: 18711076
Acute onset of leg nodules in a sporotrichoid pattern--quiz case. Diagnosis: primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL-LT).
Evans KG, Abraham RM, Mihova D, Xu X, Frank DM, Rosenbach M, Kim EJ. Evans KG, et al. Among authors: kim ej. Arch Dermatol. 2012 Oct;148(10):1199-200. doi: 10.1001/archderm.148.10.1199-b. Arch Dermatol. 2012. PMID: 23069960 No abstract available.
2,834 results
Jump to page
Feedback